These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36581096)

  • 1. Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases.
    Turkez H; Altay O; Yildirim S; Li X; Yang H; Bayram C; Bolat I; Oner S; Tozlu OO; Arslan ME; Arif M; Yulug B; Hanoglu L; Cankaya S; Lam S; Velioglu HA; Coskun E; Idil E; Nogaylar R; Ozsimsek A; Hacimuftuoglu A; Shoaie S; Zhang C; Nielsen J; Borén J; Uhlén M; Mardinoglu A
    Life Sci; 2023 Feb; 314():121325. PubMed ID: 36581096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases.
    Altay O; Yang H; Yildirim S; Bayram C; Bolat I; Oner S; Tozlu OO; Arslan ME; Hacimuftuoglu A; Shoaie S; Zhang C; Borén J; Uhlén M; Turkez H; Mardinoglu A
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial.
    Yulug B; Altay O; Li X; Hanoglu L; Cankaya S; Lam S; Velioglu HA; Yang H; Coskun E; Idil E; Nogaylar R; Ozsimsek A; Bayram C; Bolat I; Oner S; Tozlu OO; Arslan ME; Hacimuftuoglu A; Yildirim S; Arif M; Shoaie S; Zhang C; Nielsen J; Turkez H; Borén J; Uhlén M; Mardinoglu A
    Transl Neurodegener; 2023 Jan; 12(1):4. PubMed ID: 36703196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
    Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
    Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.
    Barilar JO; Knezovic A; Perhoc AB; Homolak J; Riederer P; Salkovic-Petrisic M
    J Neural Transm (Vienna); 2020 Feb; 127(2):231-250. PubMed ID: 32030485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
    Nowell J; Blunt E; Gupta D; Edison P
    Ageing Res Rev; 2023 Aug; 89():101979. PubMed ID: 37328112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.
    Xie A; Gao J; Xu L; Meng D
    Biomed Res Int; 2014; 2014():648740. PubMed ID: 24900975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
    Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
    Olesen MA; Villavicencio-Tejo F; Quintanilla RA
    Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying mechanisms in neurodegenerative diseases (NDDs) using candidate mechanism perturbation amplitude (CMPA) algorithm.
    Karki R; Kodamullil AT; Hoyt CT; Hofmann-Apitius M
    BMC Bioinformatics; 2019 Oct; 20(1):494. PubMed ID: 31604427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Bioenergetics in Neurodegeneration.
    Strope TA; Birky CJ; Wilkins HM
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration.
    Jha SK; Jha NK; Kumar D; Ambasta RK; Kumar P
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1132-1146. PubMed ID: 27345267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.
    Monzio Compagnoni G; Di Fonzo A; Corti S; Comi GP; Bresolin N; Masliah E
    Mol Neurobiol; 2020 Jul; 57(7):2959-2980. PubMed ID: 32445085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer's and Parkinson's Diseases: Insights into Current Medications.
    Gautam D; Naik UP; Naik MU; Yadav SK; Chaurasia RN; Dash D
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Briffa M; Ghio S; Neuner J; Gauci AJ; Cacciottolo R; Marchal C; Caruana M; Cullin C; Vassallo N; Cauchi RJ
    Neurosci Lett; 2017 Jan; 638():12-20. PubMed ID: 27919712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Metabolic Activators Decrease Liver Steatosis by Activating Mitochondrial Metabolism in Hamsters Fed with a High-Fat Diet.
    Yang H; Mayneris-Perxachs J; Boqué N; Del Bas JM; Arola L; Yuan M; Türkez H; Uhlén M; Borén J; Zhang C; Mardinoglu A; Caimari A
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.